JP4886976B2 - 結腸直腸のガンの予後予測 - Google Patents

結腸直腸のガンの予後予測 Download PDF

Info

Publication number
JP4886976B2
JP4886976B2 JP2004248898A JP2004248898A JP4886976B2 JP 4886976 B2 JP4886976 B2 JP 4886976B2 JP 2004248898 A JP2004248898 A JP 2004248898A JP 2004248898 A JP2004248898 A JP 2004248898A JP 4886976 B2 JP4886976 B2 JP 4886976B2
Authority
JP
Japan
Prior art keywords
patients
gene
genes
expression
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004248898A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006101701A5 (OSRAM
JP2006101701A (ja
Inventor
ワング イキシン
Original Assignee
ベリデックス リミティド ライアビリティー カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/651,237 external-priority patent/US20050048494A1/en
Application filed by ベリデックス リミティド ライアビリティー カンパニー filed Critical ベリデックス リミティド ライアビリティー カンパニー
Publication of JP2006101701A publication Critical patent/JP2006101701A/ja
Publication of JP2006101701A5 publication Critical patent/JP2006101701A5/ja
Application granted granted Critical
Publication of JP4886976B2 publication Critical patent/JP4886976B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2004248898A 2003-08-28 2004-08-27 結腸直腸のガンの予後予測 Expired - Fee Related JP4886976B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/651237 2003-08-28
US10/651,237 US20050048494A1 (en) 2003-08-28 2003-08-28 Colorectal cancer prognostics
US10/782413 2004-02-19
US10/782,413 US20060063157A9 (en) 2003-08-28 2004-02-19 Colorectal cancer prognostics

Publications (3)

Publication Number Publication Date
JP2006101701A JP2006101701A (ja) 2006-04-20
JP2006101701A5 JP2006101701A5 (OSRAM) 2011-01-13
JP4886976B2 true JP4886976B2 (ja) 2012-02-29

Family

ID=34139107

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004248898A Expired - Fee Related JP4886976B2 (ja) 2003-08-28 2004-08-27 結腸直腸のガンの予後予測

Country Status (7)

Country Link
EP (1) EP1512758B1 (OSRAM)
JP (1) JP4886976B2 (OSRAM)
KR (1) KR101128112B1 (OSRAM)
CN (1) CN1637151B (OSRAM)
AU (1) AU2004205270B2 (OSRAM)
BR (1) BRPI0403812A (OSRAM)
CA (1) CA2475769C (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
US20080058432A1 (en) * 2006-03-03 2008-03-06 Yixin Wang Molecular assay to predict recurrence of Duke's B colon cancer
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
EP2322224B1 (en) * 2008-09-01 2013-07-17 National University Corporation Nagoya University Prognosis of colon cancers
JP6608424B2 (ja) * 2014-04-10 2019-11-20 バイオ−マルケア テクノロジーズ リミテッド 前癌性結腸直腸ポリープおよび結腸直腸癌を特定するための方法およびキット
CN106367527A (zh) * 2016-11-17 2017-02-01 苏州大学附属第二医院 直肠癌放化疗疗效相关靶基因的鉴定
CN111560433B (zh) * 2020-04-28 2022-07-19 福建中医药大学 人nufip1的用途及相关产品
CN111951883A (zh) * 2020-08-04 2020-11-17 广东省第二人民医院（广东省卫生应急医院） 一种特征mRNA表达谱组合及结肠癌早期预测方法
CN114569731B (zh) * 2022-03-01 2023-05-05 山东大学 一种分子信标修饰的纳米载体及在制备抗肿瘤产品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229770B1 (en) * 1998-10-01 2007-06-12 The Regents Of The University Of California YKL-40 as a marker and prognostic indicator for cancers
JPH0856699A (ja) * 1994-08-25 1996-03-05 Tabiti Karim 腫瘍診断及び予後
EP1358349A2 (en) * 2000-06-05 2003-11-05 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
CA2412223A1 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
AU2002255478A1 (en) * 2001-01-10 2002-09-12 Pe Corporation (Ny) Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof
CA2463143A1 (en) * 2001-10-31 2003-07-10 Alcon, Inc. Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
US7348142B2 (en) * 2002-03-29 2008-03-25 Veridex, Lcc Cancer diagnostic panel
US20030186303A1 (en) * 2002-03-29 2003-10-02 Yixin Wang Colorectal cancer diagnostics
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
RU2278764C1 (ru) * 2005-02-11 2006-06-27 Юрий Васильевич Мартемьянов Способ прессования из жидкого металла изделий неограниченной длины

Also Published As

Publication number Publication date
EP1512758A1 (en) 2005-03-09
CA2475769A1 (en) 2005-02-28
AU2004205270B2 (en) 2009-01-22
CN1637151B (zh) 2013-07-17
KR101128112B1 (ko) 2012-09-05
CN1637151A (zh) 2005-07-13
AU2004205270A1 (en) 2005-03-17
BRPI0403812A (pt) 2005-06-07
EP1512758B1 (en) 2012-10-17
CA2475769C (en) 2018-12-11
JP2006101701A (ja) 2006-04-20
KR20050021916A (ko) 2005-03-07

Similar Documents

Publication Publication Date Title
US8183353B2 (en) Breast cancer prognostics
EP1526186B1 (en) Colorectal cancer prognostics
KR101530689B1 (ko) 직장결장암용 예후 예측
US8642279B2 (en) Method for predicting risk of metastasis
JP5089993B2 (ja) 乳癌の予後診断
AU2008203226B2 (en) Colorectal cancer prognostics
JP2009528825A (ja) デュークスｂ大腸がんの再発を予測するための分子的解析
JP2008521412A (ja) 肺癌予後判定手段
EP2158332A1 (en) Prognosis prediction for melanoma cancer
JP2009153521A (ja) 結腸直腸癌の評価
JP2009153522A (ja) 結腸直腸癌の評価
US20250137066A1 (en) Compostions and methods for diagnosing lung cancers using gene expression profiles
US20050186577A1 (en) Breast cancer prognostics
JP2006101701A (ja) 結腸直腸のガンの予後予測
US8105777B1 (en) Methods for diagnosis and/or prognosis of colon cancer
JP2008538284A (ja) 乳房の腫瘍のレーザーマイクロダイセクションおよびマイクロアレイ解析が、エストロゲン受容体に関係する遺伝子および経路を明らかにする

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070710

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100518

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100817

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100820

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20101118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111101

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20111206

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111212

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141216

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4886976

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees